Related Experiment Videos
Aspergillus discitis. Report of two cases and review of the literature
P F Holmes1, D W Osterman, H S Tullos
1Division of Orthopedic Surgery, Baylor College of Medicine, Houston 77030.
Abstract:
Aspergillus discitis is a rare disease that usually occurs in immunocompromised hosts. In the one case reported in the orthopedic literature surgical debridement was required. Two additional cases, which occurred in intravenous drug abusers, are reported here. One case is unique in the orthopedic literature in that eradication of the disease occurred with chemotherapy alone.
Insights
Aspergillus discitis, a rare spinal infection, typically affects immunocompromised individuals. This study highlights a unique case successfully treated with chemotherapy alone, offering a novel therapeutic approach for this challenging condition.
Area of Science:
- Infectious Diseases
- Orthopedics
- Medical Mycology
Background:
- Aspergillus discitis is a rare but serious spinal infection.
- It predominantly affects immunocompromised patients.
- Surgical intervention has been the standard treatment approach.
Observation:
- Two cases of Aspergillus discitis in intravenous drug abusers are presented.
- These patients represent a distinct demographic for this infection.
- One patient had a history of intravenous drug abuse.
Findings:
- Surgical debridement was previously the only reported orthopedic treatment.
- One patient achieved disease eradication with chemotherapy alone.
- This represents a unique non-surgical treatment success in the orthopedic literature.
Implications:
- Chemotherapy alone may be a viable treatment option for select cases of Aspergillus discitis.
- This finding challenges the necessity of surgical debridement in all instances.
- Further research is warranted to explore non-operative management strategies for invasive fungal infections of the spine.